Chengdu Kanghua Biological's low P/E ratio, poor earnings an...
Chengdu Kanghua Biological's low P/E ratio, poor earnings and projected growth below market average may impact future share price. A significant rise in share price is unlikely in the near future.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000287398ac8ecc8c.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment